EHMTI-0062. Expression of fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) in the trigeminal ganglia: implications for craniofacial nociception

Lignende værker

• Up regulated expression of fractalkine/CX(3)CL1 and CX(3)CR1 in patients with systemic sclerosis
  af: Hasegawa, M, et al.
  Udgivet: (2005)
• Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in periodontal diseased tissue
  af: Hosokawa, Y, et al.
  Udgivet: (2005)
• The Chemokine CX3CL1 (Fractalkine) and its Receptor CX3CR1: Occurrence and Potential Role in Osteoarthritis
  af: Wojdasiewicz, Piotr, et al.
  Udgivet: (2014)
• Therapeutic intervention of inflammatory/immune diseases by inhibition of the fractalkine (CX3CL1)-CX3CR1 pathway
  af: Imai, Toshio, et al.
  Udgivet: (2016)
• Elevated Expression of Fractalkine (CX3CL1) and Fractalkine Receptor (CX3CR1) in the Dorsal Root Ganglia and Spinal Cord in Experimental Autoimmune Encephalomyelitis: Implications in Multiple Sclerosis-Induced Neuropathic Pain
  af: Zhu, Wenjun, et al.
  Udgivet: (2013)